Contact us | Home
Contract Vehicles
Tuberculosis Indefinite Quantity Contract (IQC)
Contracting Agency: United States Agency for International Development
TB is a preventable and curable disease but continues to pose a global menace. About one-third of the world's population is infected and nearly 2 million people die from TB each year.
URC leads a team to support the US Agency for International Development (USAID) in developing and strengthening tuberculosis (TB) programs worldwide. The agreement, an Indefinite Quantity Contract (IQC), provides the USAID Global Health Bureau and missions with a way to obtain expert advice and assistance from URC's team on how to build and expand sustainable TB control and prevention programs in countries most heavily impacted by the disease.
This contract entitled TB IQC follows the Technical Assistance and Support II TB IQC that URC previously managed.
The URC TB IQC team approach is grounded in the Stop TB strategy including Directly Observed Treatment, Short Course (DOTS).
Key Services
- Expand DOTS to increase case detection case-finding and improve treatment success rates
- Improve cross-referral services for HIV and TB patients
- Strengthen linkages between health facilities and laboratory networks
- Increase access to TB diagnostics
- Improve quality of supervision and train health care workers to develop case management skills
- Conduct Public-Private Mix DOTS training in collaboration with national treatment programs, as well as improve referrals of patients from the private sector where DOTS cannot be administered
- Develop and implement national and local advocacy, communication, and social mobilization strategies
URC Partnership
The IQC Contract Partnership includes organizations with reputed experts and a global presence: Center for Tuberculosis Research and the Center for Communications Programs of the Johns Hopkins Bloomberg School of Public Health; American Society for Clinical Pathology; Global Health Advocates; Constella Futures International; Family Health International; Jhpiego; Liverpool Associates in Tropical Health, Ltd; McGill University; Emory University; National Jewish Health; Aeras Global TB Vaccine Foundation; University of California at Los Angeles; Westat, BEA Enterprises; Innovative Development Expertise & Advisory Services; O’Brien and Associates; and Overseas Strategic Consulting, Ltd.
For More Information
For more information on the TB IQC award, please contact Stacy Kancijanic at skancijanic@urc-chs.com.
Back to top |
